1096703-33-1

Basic information

• Product Name: ethyl 2-(4-chloro-3-fluorophenoxy)acetate
• Synonyms: ethyl 2-(4-chloro-3-fluorophenoxy)acetate
• CAS NO: 1096703-33-1
• Molecular Weight: 232.639
• Mol File: 1096703-33-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: ethyl 2-(4-chloro-3-fluorophenoxy)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-(4-chloro-3-fluorophenoxy)acetate(1096703-33-1)
• EPA Substance Registry System: ethyl 2-(4-chloro-3-fluorophenoxy)acetate(1096703-33-1)

Safety Data

• Hazardous Substances Data: 1096703-33-1(Hazardous Substances Data)

Upstream product

• 348-60-7 4-chloro-3-fluorophenol 
• 105-36-2 ethyl bromoacetate 
• 105-39-5 chloroacetic acid ethyl ester 

Downstream Products

• 1547-07-5 <3-Fluor-4-chlorphenoxy>-acethydroxamsaeure 
• 1096703-00-2 2-(4-Chloro-3-fluoro-phenoxymethyl)-4,5-dihydro-1H-imidazole 
• 331-41-9 2-(4-chloro-3-fluorophenoxy)acetic acid 
• 1370228-12-8 1,4-diethyl 2-(4-chloro-3-fluorophenoxy)-3-oxobutanedioate 

Relevant articles and documents

Synthesis and larvicidal activity of 1,3,4-oxadiazole derivatives containing a 3-chloropyridin-2-yl-1H-pyrazole scaffold

Abstract: A new series of 1,3,4-oxadiazole derivatives with a 3-chloropyridin-2-yl-1H-pyrazole moiety was designed, synthesized, and characterized. The results of bioassay against Helicoverpa armigera and Plutella xylostella indicated that some of the synthesized compounds showed remarkable larvicidal activity. In particular, the LC50 values of the most active compounds against P. xylostella were 46.5, 23.9, and 13.9?mg/dm3, and against Helicoverpa armigera were 88.3 and 69.5?mg/dm3, the latter being slightly better than commercial chlorpyrifos (LC50 103.77?mg/dm3). Preliminary SAR was also discussed. Graphical abstract: [Figure not available: see fulltext.].

7-HYDROXY-PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AND THEIR USE AS CCR2 RECEPTOR ANTAGONISTS

The compounds of formula (I) are antagonists of the CCR2 receptor Wherein R1-7 and A are as defined in the claims.

2-IMIDAZOLINES

The present invention relates to compounds of formula I wherein X—Y, R1, and n are as defined herein and to their pharmaceutically active salts. Compounds of formula I have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1 and are useful for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.